SEC Form 4 · accession 0001209191-16-149054
INTEGRA LIFESCIENCES HOLDINGS CORP · IART
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter J Arduini
Officer — President & CEO · Director
Period of report
Nov 7, 2016
Accepted (ET)
Nov 9, 2016 · 4:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000917520
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Nov 7, 2016 | S | 4,009 | $77.0037 | D | 25,593 | D | |
| Common Stock | Nov 8, 2016 | M | 20,000 | $27.78 | A | 45,593 | D | |
| Common StockF3 | Nov 8, 2016 | S | 20,000 | $80.0151 | D | 25,593 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F4 | $27.78 | Nov 8, 2016 | M | 20,000 | D | — | Mar 1, 2020 | Common Stock | 20,000 | 175,794 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- F2The price shown above represents the weighted average price of the shares sold. The range of sale prices was $77.00 to $77.02.
- F3The price shown above represents the weighted average price of the shares sold. The range of sale prices was $80.00 to $80.11.
- F4One-third of the stock options vested on the first anniversary of the grant date which is March 1, 2012 and thereafter with respect to the remaining two-thirds which vested in monthly installments through the 3rd anniversary of the grant date.